Loading…
Interferon-Induced Psychosis as a “Psychiatric Contraindication” to Hepatitis C Treatment: A Review and Case-Based Discussion
Background Hepatitis C (HCV) infection is a major cause of liver disease, cirrhosis, and hepatocellular carcinoma. Interferon-based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms. Objective The authors describ...
Saved in:
Published in: | Psychosomatics (Washington, D.C.) D.C.), 2010-01, Vol.51 (1), p.1-7 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3554-e5838fb05110fa5dbe8179bd72f981cb59046005e1d536d1022d6094adc728a63 |
---|---|
cites | cdi_FETCH-LOGICAL-c3554-e5838fb05110fa5dbe8179bd72f981cb59046005e1d536d1022d6094adc728a63 |
container_end_page | 7 |
container_issue | 1 |
container_start_page | 1 |
container_title | Psychosomatics (Washington, D.C.) |
container_volume | 51 |
creator | Silverman, Benjamin C., M.D Kim, Arthur Y., M.D Freudenreich, Oliver, M.D |
description | Background Hepatitis C (HCV) infection is a major cause of liver disease, cirrhosis, and hepatocellular carcinoma. Interferon-based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms. Objective The authors described a case of interferon-induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C. Method The authors followed a patient with chronic HCV who received interferon and ribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization. Results Despite treatment with various neuroleptics, the psychosis resolved only when the interferon/ribavirin were discontinued. Conclusion Psychiatric illness should not rule out the possibility of interferon-based therapy, but it calls for close integration of psychiatric and medical care and individualized decision-making based on the biological and psychosocial circumstances of each case. |
doi_str_mv | 10.1016/S0033-3182(10)70652-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_220154630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0033318210706526</els_id><sourcerecordid>1959556051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3554-e5838fb05110fa5dbe8179bd72f981cb59046005e1d536d1022d6094adc728a63</originalsourceid><addsrcrecordid>eNqFkd2KEzEYhoMobl29BCUIgh6M5n-me6Cs488WFhRdj0Mm-QaztpmaZJSerfehN7dXYqatFTwRQkLC-z3J9wSh-5Q8pYSqZx8J4bzitGGPKXlSEyVZpW6gGZVCVjUj6iaaHSJH6E5Kl4QQSaW6jY4YobQRXMzQj0XIEHuIQ6gWwY0WHH6fNvbzkHzCpgx8ffVze-JNjt7idgg5Gh-ctyb7IVxf_cJ5wGewLttcilp8EcHkFYR8gk_xB_jm4Ts2weHWJKhelsnhVz7ZMaVSfxfd6s0ywb39eow-vXl90Z5V5-_eLtrT88pyKUUFsuFN35UOKOmNdB00tJ53rmb9vKG2k3MiVGkQqJNcOUoYc4rMhXG2Zo1R_Bg93HHXcfg6Qsr6chhjKFdqVnxIoTgpIbkL2TikFKHX6-hXJm40JXryrrfe9SR1Otp61xP8wR4-ditwh6o_okvg0T5gkjXLPppgffqbY1wxISbQi10OiooiLupkPYTyLT6CzdoN_r9Pef4PwS59KJ-1_AIbSIemqU5Mkx1kYlCyJSj-G_hNtQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220154630</pqid></control><display><type>article</type><title>Interferon-Induced Psychosis as a “Psychiatric Contraindication” to Hepatitis C Treatment: A Review and Case-Based Discussion</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Silverman, Benjamin C., M.D ; Kim, Arthur Y., M.D ; Freudenreich, Oliver, M.D</creator><creatorcontrib>Silverman, Benjamin C., M.D ; Kim, Arthur Y., M.D ; Freudenreich, Oliver, M.D</creatorcontrib><description>Background Hepatitis C (HCV) infection is a major cause of liver disease, cirrhosis, and hepatocellular carcinoma. Interferon-based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms. Objective The authors described a case of interferon-induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C. Method The authors followed a patient with chronic HCV who received interferon and ribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization. Results Despite treatment with various neuroleptics, the psychosis resolved only when the interferon/ribavirin were discontinued. Conclusion Psychiatric illness should not rule out the possibility of interferon-based therapy, but it calls for close integration of psychiatric and medical care and individualized decision-making based on the biological and psychosocial circumstances of each case.</description><identifier>ISSN: 0033-3182</identifier><identifier>EISSN: 1545-7206</identifier><identifier>DOI: 10.1016/S0033-3182(10)70652-6</identifier><identifier>PMID: 20118434</identifier><language>eng</language><publisher>Arlington, VA: Elsevier Inc</publisher><subject>Adult ; Adult and adolescent clinical studies ; Antiviral Agents - adverse effects ; Biological and medical sciences ; Drug toxicity and drugs side effects treatment ; Female ; Hepatitis C - drug therapy ; Humans ; Interferons - adverse effects ; Internal Medicine ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Other psychotic disorders ; Pharmacology. Drug treatments ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Psychoses, Substance-Induced - diagnosis ; Psychoses, Substance-Induced - etiology ; Psychoses, Substance-Induced - psychology ; Psychosis ; Ribavirin - adverse effects ; Severity of Illness Index</subject><ispartof>Psychosomatics (Washington, D.C.), 2010-01, Vol.51 (1), p.1-7</ispartof><rights>The Academy of Psychosomatic Medicine</rights><rights>2011 The Academy of Psychosomatic Medicine</rights><rights>2015 INIST-CNRS</rights><rights>Copyright American Psychiatric Publishing, Inc. Jan/Feb 2010</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3554-e5838fb05110fa5dbe8179bd72f981cb59046005e1d536d1022d6094adc728a63</citedby><cites>FETCH-LOGICAL-c3554-e5838fb05110fa5dbe8179bd72f981cb59046005e1d536d1022d6094adc728a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22362446$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20118434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silverman, Benjamin C., M.D</creatorcontrib><creatorcontrib>Kim, Arthur Y., M.D</creatorcontrib><creatorcontrib>Freudenreich, Oliver, M.D</creatorcontrib><title>Interferon-Induced Psychosis as a “Psychiatric Contraindication” to Hepatitis C Treatment: A Review and Case-Based Discussion</title><title>Psychosomatics (Washington, D.C.)</title><addtitle>Psychosomatics</addtitle><description>Background Hepatitis C (HCV) infection is a major cause of liver disease, cirrhosis, and hepatocellular carcinoma. Interferon-based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms. Objective The authors described a case of interferon-induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C. Method The authors followed a patient with chronic HCV who received interferon and ribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization. Results Despite treatment with various neuroleptics, the psychosis resolved only when the interferon/ribavirin were discontinued. Conclusion Psychiatric illness should not rule out the possibility of interferon-based therapy, but it calls for close integration of psychiatric and medical care and individualized decision-making based on the biological and psychosocial circumstances of each case.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Antiviral Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Hepatitis C - drug therapy</subject><subject>Humans</subject><subject>Interferons - adverse effects</subject><subject>Internal Medicine</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Other psychotic disorders</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Psychoses, Substance-Induced - diagnosis</subject><subject>Psychoses, Substance-Induced - etiology</subject><subject>Psychoses, Substance-Induced - psychology</subject><subject>Psychosis</subject><subject>Ribavirin - adverse effects</subject><subject>Severity of Illness Index</subject><issn>0033-3182</issn><issn>1545-7206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkd2KEzEYhoMobl29BCUIgh6M5n-me6Cs488WFhRdj0Mm-QaztpmaZJSerfehN7dXYqatFTwRQkLC-z3J9wSh-5Q8pYSqZx8J4bzitGGPKXlSEyVZpW6gGZVCVjUj6iaaHSJH6E5Kl4QQSaW6jY4YobQRXMzQj0XIEHuIQ6gWwY0WHH6fNvbzkHzCpgx8ffVze-JNjt7idgg5Gh-ctyb7IVxf_cJ5wGewLttcilp8EcHkFYR8gk_xB_jm4Ts2weHWJKhelsnhVz7ZMaVSfxfd6s0ywb39eow-vXl90Z5V5-_eLtrT88pyKUUFsuFN35UOKOmNdB00tJ53rmb9vKG2k3MiVGkQqJNcOUoYc4rMhXG2Zo1R_Bg93HHXcfg6Qsr6chhjKFdqVnxIoTgpIbkL2TikFKHX6-hXJm40JXryrrfe9SR1Otp61xP8wR4-ditwh6o_okvg0T5gkjXLPppgffqbY1wxISbQi10OiooiLupkPYTyLT6CzdoN_r9Pef4PwS59KJ-1_AIbSIemqU5Mkx1kYlCyJSj-G_hNtQQ</recordid><startdate>201001</startdate><enddate>201001</enddate><creator>Silverman, Benjamin C., M.D</creator><creator>Kim, Arthur Y., M.D</creator><creator>Freudenreich, Oliver, M.D</creator><general>Elsevier Inc</general><general>American Psychiatric Publishing</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>201001</creationdate><title>Interferon-Induced Psychosis as a “Psychiatric Contraindication” to Hepatitis C Treatment: A Review and Case-Based Discussion</title><author>Silverman, Benjamin C., M.D ; Kim, Arthur Y., M.D ; Freudenreich, Oliver, M.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3554-e5838fb05110fa5dbe8179bd72f981cb59046005e1d536d1022d6094adc728a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Antiviral Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Hepatitis C - drug therapy</topic><topic>Humans</topic><topic>Interferons - adverse effects</topic><topic>Internal Medicine</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Other psychotic disorders</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Psychoses, Substance-Induced - diagnosis</topic><topic>Psychoses, Substance-Induced - etiology</topic><topic>Psychoses, Substance-Induced - psychology</topic><topic>Psychosis</topic><topic>Ribavirin - adverse effects</topic><topic>Severity of Illness Index</topic><toplevel>online_resources</toplevel><creatorcontrib>Silverman, Benjamin C., M.D</creatorcontrib><creatorcontrib>Kim, Arthur Y., M.D</creatorcontrib><creatorcontrib>Freudenreich, Oliver, M.D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Psychosomatics (Washington, D.C.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silverman, Benjamin C., M.D</au><au>Kim, Arthur Y., M.D</au><au>Freudenreich, Oliver, M.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interferon-Induced Psychosis as a “Psychiatric Contraindication” to Hepatitis C Treatment: A Review and Case-Based Discussion</atitle><jtitle>Psychosomatics (Washington, D.C.)</jtitle><addtitle>Psychosomatics</addtitle><date>2010-01</date><risdate>2010</risdate><volume>51</volume><issue>1</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>0033-3182</issn><eissn>1545-7206</eissn><abstract>Background Hepatitis C (HCV) infection is a major cause of liver disease, cirrhosis, and hepatocellular carcinoma. Interferon-based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms. Objective The authors described a case of interferon-induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C. Method The authors followed a patient with chronic HCV who received interferon and ribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization. Results Despite treatment with various neuroleptics, the psychosis resolved only when the interferon/ribavirin were discontinued. Conclusion Psychiatric illness should not rule out the possibility of interferon-based therapy, but it calls for close integration of psychiatric and medical care and individualized decision-making based on the biological and psychosocial circumstances of each case.</abstract><cop>Arlington, VA</cop><pub>Elsevier Inc</pub><pmid>20118434</pmid><doi>10.1016/S0033-3182(10)70652-6</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3182 |
ispartof | Psychosomatics (Washington, D.C.), 2010-01, Vol.51 (1), p.1-7 |
issn | 0033-3182 1545-7206 |
language | eng |
recordid | cdi_proquest_journals_220154630 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Adult Adult and adolescent clinical studies Antiviral Agents - adverse effects Biological and medical sciences Drug toxicity and drugs side effects treatment Female Hepatitis C - drug therapy Humans Interferons - adverse effects Internal Medicine Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Other psychotic disorders Pharmacology. Drug treatments Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Psychoses, Substance-Induced - diagnosis Psychoses, Substance-Induced - etiology Psychoses, Substance-Induced - psychology Psychosis Ribavirin - adverse effects Severity of Illness Index |
title | Interferon-Induced Psychosis as a “Psychiatric Contraindication” to Hepatitis C Treatment: A Review and Case-Based Discussion |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A32%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interferon-Induced%20Psychosis%20as%20a%20%E2%80%9CPsychiatric%20Contraindication%E2%80%9D%20to%20Hepatitis%20C%20Treatment:%20A%20Review%20and%20Case-Based%20Discussion&rft.jtitle=Psychosomatics%20(Washington,%20D.C.)&rft.au=Silverman,%20Benjamin%20C.,%20M.D&rft.date=2010-01&rft.volume=51&rft.issue=1&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=0033-3182&rft.eissn=1545-7206&rft_id=info:doi/10.1016/S0033-3182(10)70652-6&rft_dat=%3Cproquest_cross%3E1959556051%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3554-e5838fb05110fa5dbe8179bd72f981cb59046005e1d536d1022d6094adc728a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=220154630&rft_id=info:pmid/20118434&rfr_iscdi=true |